Arcutis Biotherapeutics, Inc. — All Filings
773 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CORRESP | — | 0001193125-20-016867 | Jan 28, 2020 | — |
| SEC STAFF LETTER | — | 9999999997-20-000311 | Jan 27, 2020 | — |
| S-1/A | S-1/A | 0001193125-20-010664 | Jan 21, 2020 | — |
| 8-A12B | 8-A12B | 0001193125-20-011069 | Jan 21, 2020 | — |
| CORRESP | — | 0001193125-20-006564 | Jan 13, 2020 | — |
| S-1 | S-1 | 0001193125-20-001990 | Jan 6, 2020 | — |
| DRS/A | — | 0000950123-19-011884 | Dec 13, 2019 | — |
| DRS/A | — | 0000950123-19-010644 | Nov 12, 2019 | — |
| DRSLTR | — | 0000950123-19-010645 | Nov 12, 2019 | — |
| UPLOAD | — | 0000000000-19-015031 | Oct 31, 2019 | — |
| D | — | 0001787306-19-000002 | Oct 22, 2019 | — |
| DRS/A | — | 0000950123-19-009590 | Oct 21, 2019 | — |
| DRSLTR | — | 0000950123-19-009591 | Oct 18, 2019 | — |
| UPLOAD | — | 0000000000-19-014334 | Oct 7, 2019 | — |
| DRS | — | 0000950123-19-008834 | Sep 9, 2019 | — |